Advertisement
Wolves signed McCarey from Monaghan United in 2010. PA Archive/Press Association Images
Controversy

Former Ireland U21 international fails drugs test

Wolves’ Aaron McCarey denies any wrongdoing.

FORMER IRELAND U21 international Aaron McCarey has failed a drug test for a non-performance enhancing substance, it has been confirmed.

McCarey’s club Wolves, who signed him from Monaghan United in 2010, have tonight issued a statement in relation to the player — who denies any wrongdoing — that reads as follows:

“Aaron McCarey has failed an out of competition Football Association (FA) drug test for a non-performance enhancing substance.

“As a result, the Wolves goalkeeper is now subject to an immediate FA suspension from all competitive forms of football.

“The immediate suspension is a standard procedure whilst the FA’s investigation is concluded.

“Aaron McCarey strenuously denies deliberately taking any banned substance.

“The Club is extremely disappointed and concerned that one of its players has failed a drugs test.

“Neither the player nor the Club will be making any further comment whilst the FA investigation is underway and not until the matter has been fully concluded.”

The news comes less than 48 hours after Hull’s Jake Livermore and Sheffield United’s Jose Baxter were both reported to have failed drugs tests.

23-year-old McCarey, who was born in Monaghan, has been largely a reserve goalkeeper at Wolves and has been sent out on loan a number of times by the club, spending part of last season at League Two side York City.

The goalkeeper was called up to the Irish senior squad in 2013 for a friendly against Spain in New York, but didn’t feature in the game.

No fairytale ending to life at Anfield as Gerrard says an emotional goodbye to Reds fans>

Wes Hoolahan scores as Norwich book their place in the play-off final>

Your Voice
Readers Comments
20
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.